研究目的
Treating solar lentigines with two different techniques of pulsed dye laser and evaluation of the results both clinically and via the examination of ultrastructural changes by electron microscopy.
研究成果
Two stacked pulsed dye laser with one month apart is a successful and safe option in the management of solar lentigines lesions. However, further longitudinal controlled studies with a large population size are needed to confirm these outcomes.
研究不足
The study was conducted on a small sample size of twenty-two patients. Further longitudinal controlled studies with a large population size are needed to confirm these outcomes.
1:Experimental Design and Method Selection:
A prospective, randomized, double-blinded, parallel-design comparative clinical trial was conducted on twenty-two patients in two treatment groups with a 1:1 allocation ratio and with a follow-up of six months. Participants were treated by PDL (DEKA, Synchrovasq, Serial number: QA3B2501, Italy) at 595nm wavelength with parameters of the handpiece 8, rate 1 HZ, fluence 5-7 J/cm2, pulse width
2:5 ms and air cooling. Sample Selection and Data Sources:
Patients included in this study were having pathologically confirmed solar lentigines with skin types III and IV for more than one year and discontinued topical treatment at least 6 weeks prior to starting the study.
3:List of Experimental Equipment and Materials:
Pulsed dye laser (DEKA, Synchrovasq, Serial number: QA3B2501, Italy), digital camera Sony: Cyber – ShotDSC-W690, punch skin biopsies.
4:Experimental Procedures and Operational Workflow:
Patients were divided into two groups. Group I: Eleven patients treated by one stacked PDL session. Group II: Eleven patients managed by two stacked PDL sessions with a one-month interval. Punch skin biopsies were taken before and six months following PDL therapy.
5:Data Analysis Methods:
Data were analyzed utilizing statistical software package (SPSS version 20, Armonk, NY: IBM Corp).
独家科研数据包,助您复现前沿成果,加速创新突破
获取完整内容